TriGemX Bio, formerly known as Kallyope, is commercializing technology developed by Columbia's Dr. Charles Zuker, Dr. Tom Maniatis, and Dr. Richard Axel.
NOVAKnee, a “living knee” implant, has been named one of TIME’s Best Inventions of 2026. The project is co-led by Columbia's Dr. Clark Hung and Dr. Nadeen Chahine.
Ferass Abuzaina is one of CTV's Executives in Residence.
Columbia Technology Ventures co-sponsored the Climate Week panel with Columbia Engineering, Columbia Climate School, and Lamont Doherty Earth Observatory.
Tangent Robotics was spun out of Columbia Engineering's Robotic Manipulation and Mobility Lab and co-founded by Dr. Matei Ciocarlie, Dr. Ioannis Kymissis, and Dr. Pedro Piacenza.
Dr. Gordana Vunjak-Novakovic and her team have developed a multi-organ chip that mimics how cancer cells spread from vascular flow to distant organs, the first model of cancer metastasis of its kind.
Two companies based on Columbia technology are part of Activate New York's 2026 cohort: Nanovib is spun out of Dr. Wei Min's lab, and Redox Metals is spun out of Dr. Alan West's lab.
The Carbontech Development Initiative (CDI) is pleased to announce its final funding awards totaling more than $2.3 million to startups and academic institutions working to develop and scale critical carbon-related technologies.
Developed by Dr. Pierre Elias, EchoNext is the world’s first FDA-approved AI detection tool that analyzes electrocardiograms (ECGs) to detect high-risk structural heart disease.
EchoNext, an artificial intelligence tool developed by Dr. Pierre Elias, has received the world’s first FDA clearance for AI detection of hidden heart disease through electrocardiograms (ECGs).
Belite Bio is commercializing technology developed by Columbia's Dr. Konstantin Petrukhin.
Dr. Acharyya's project will examine how ovarian tumors may activate stress-response pathways in the brain that subsequently promote cancer spread. Dr. Danino's project seeks to develop engineered probiotic bacteria that can selectively colonize ovarian tumors and deliver therapeutic molecules directly within the tumor microenvironment.